Professional Documents
Culture Documents
Female Genital Tract II
Female Genital Tract II
immunocompromised
TRACT
4. Trichomonas vaginalis
Protozoa
Purulent discharge
5. Gardenella vaginalis
inclusions
Gram (-)
3. Yeast (Candida)
discharge
Squamous
cells
covered
by
multiple
coccobacilli
in
pap
smear
(clue
cells)
Mycoplasma hominis
7. Chlamydia trachomatis
neutrophils)
salpingitis
epithelium
Disease (PID)
PID: COMPLICATIONS
1. Peritonitis
INVOLVING
THE
LOWER
AND
UPPER
GENITAL TRACT
suppurative
arthritis
4. Tubal
obstruction
and
infertility
(
vaginal discharge
gonorrhea in women
pregnancy
(polymicrobial)
VULVA
2. Gonococcus
Bartholin Cyst
Neoplasms
salpingitis salpingo-oophoritis
PATHOLOGY
BARTHOLIN
CYST
infiltrate
permanently)
chronicus
NON-NEOPLASTIC EPITHELIAL
DISORDERS
pruritus
pre-malignant, malignant
leukoplakia
Hyperkeratosis
Leukocytic
infiltration
of
the
dermis
1. Lichen sclerosus
Unknown etiology
Labial atrophy
Narrowed introitus
plaques)= STD
women
(fibrous/blood vessels)
epidermis
Hyperkeratosis
Dermal fibrosis
4
Caused
by
low
oncogenic
risks
HPV
(6
&
11)
TWO
GROUPS:
1. BASALOID
AND
WARTY
CARCINOMAS:
TUMORS
Multicentric
10-30%
VIN
have
vaginal/cervical
HPV
3. Malignant Melanoma
related lesions
majority: + HPV 16
VULVAR CARCINOMA
Uncommon
immunosuppression
PATHOLOGY
BASALOID
WARTY
Exophytic, papillary
small, tightly
architecture
VULVAR
INTRAEPITHELIAL
NEOPLASIA
Risk
of
cancer
development
is
principally
packed
malignant
squamous
cells
lacking
immune
status.
Metastatic
spread
is
limited
to
the
size
maturation
Resembles
Prominent koilocyte
immature cells
atypia
PAPILLARY HIDRADENOMA
of normal
epithelium
Foci
of
central
tendency to ulcerate
necrosis
KERATINIZING
SQUAMOUS
CELL
CARCINOMAS
myoepithelial
cells
EXTRAMAMMARY
PAGETS
DISEASE
Pruritic,
red,
crusted
sharply
demarcated
maplike
area
in
the
labia
majora
Large
tumor
cells
lying
singly
or
in
small
6
Cells
are
distinguished
by
clear
lesions
ADENOCARCINOMA
Increase
frequency
of
clear
cell
during pregnancy
MALIGNANT MELANOMA
15-20 years
the
endocervix
PRE-MALIGNANT
AND
MALIGNANT
NEOPLASM
Most
common
malignant
tumor
of
the
VAGINA
Developmental Anomalies
cervix
2. Embryonal
Rhabdomyosarcoma
Vaginal
IN
Primary
Carcinoma
of
Vagina:
Uncommon;
1%
Almost
all=>
squamous
cell
carcinoma
(high
oncogenic
risk
HPV
associated)
Greater
risk
factor:
previous
cancer
of
cervix
or
vulva
PATHOLOGY
Arise
from
Vaginal
IN
(premalignant,
analogous
to
cervical
SILs)
CERVICAL
CARCINOMA
8TH
leading
cause
of
cancer
mortality
EMBRYONAL
RHABDOMYOSARCOMA
Sarcoma
botryoides
like clusters
carcinomas.
Malignant
chemotherapy
CERVIX
4. High parity
Endocervical
Polyps
Pre-malignant-Malignant
Neoplasms
(CIN
and
Cervical
Carcinoma)
8. Use of OCP
9. Use
of
nicotine
ENDOCERVICAL POLYPS
Risk Factors:
CERVICAL
IN
Cervical
pre-cancerous
lesions
Classification
1. Dysplasia/
carcinoma
in
situ
2. CIN
I
(mild
dysplasia)
to
II
(ca
in
situ)
8
3. Low
grade
(CIN
I)
and
high
grade
(CN
II
(CIN)
>80%
of
LSILs
and
100%
HSILs
are
HPVs
infection
carcinoma
environmental factors
CERVICAL
CARCINOMAS
SCCA:
most
important
histologic
subtype
(80%)
HSIL:
immediate
precursor
of
cervical
SCCA
keratinizing/non-keratinizing invading
cervical stroma
ADENOCARCINOMA
surface.
PATHOLOGY
ADENOSQUAMOUS CARCINOMA
NEUROENDOCRINE CARCINOMA
of the lungs
dissemination.
by microscopy
testing)
precancerous
(microinvasive carcinoma)
than 7mm
2. Secretory
3. Menstrual
10
Gland
mitoses:
proliferative
and lymphocytes
ENDOMETRIOSIS
Secretion: secretory
uterus
anong phase.
INFLAMMATION
laparotomy scars.
ACUTE ENDOMETRITIS
CHRONIC ENDOMETRITIS
ACUTE ENDOMETRITIS
Origins:
Uncommon
cavity
Spread
of
endometriosis
to
distant
CHRONIC ENDOMETRITIS
metastases.
Chronic PID
epithelium.
Tuberculosis
PATHOLOGY
Foci
of
endometriosis
respond
to
both
(functional polyps)
bleeding
ENDOMETRIAL
HYPERPLASIA
bleeding
Increase
proliferation
of
endometrial
periuterine adhesions.
endometrium
Associated
with
prolonged
estrogen
ADENOMYOSIS
myometrium.
exogenous.
gene
(nodular)
hyperplasia:
ENDOMETRIAL POLYPS
1. Obesity
2. Menopause
Asymptomatic
ovary
5. Excessive
cortical
function
(cortical
stromal
hyperplasia)
12
6. Prolonged
administration
of
estrogenic
ATYPIA
therapy)
4 CATEGORIES:
branching.
3%--> carcinoma
ATYPIA
Cystic/mild hyperplasia
differentiated endometrioid
adenocarcinoma
Uncommonly progress: 1%
performed
estrogen stimulation
ENDOMETRIAL CARCINOMA
epithelium
women
prominent nucleoli
(peak 55-65)
TYPE I:
membrane
8%
progress
to
carcinoma
PATHOLOGY
-
Well-differentiated
and
mimic
Type II:
(endometrioid cancer)
atrophy
-By
definition
poorly
differentiated
(G3)
Associated with:
tumors
1. Obesity
cancer
-Most
common
subtype
is
SEROUS
3. Hypertension
CARCINOMA.
tumor
suppressor gene
peritoneal surfaces.
All
non-endometrial
carcinomas
are
Grading
G3
TUMORS (MMMT)
Carcinosarcomas
Consist
of
endometrial
adenoCA
in
which
14
Post
menopausal
women,
and
present
to adenoCA)